Jeff Evanson is CCO at Outlook Therapeutics, Inc. (OTLK). They have made 6 open-market trades across 1 company since 2021, most recently 2024-03-07.
CIK 0001760511
2 open-market purchases totalling $73K since 2021, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OTLK | 808,459 | $394K |
Shares reported on the most recent Form 4, priced at the 2024-03-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OTLK | BUY | 2024-03-07 | 2024-03-11 | $0.42 | $26K | -4.9% | +21.5% | -4.5% |
| OTLK | SELL | 2023-01-20 | 2023-01-24 | $1.11 | $296K | +5.5% | +6.9% | +0.0% |
| OTLK | SELL | 2023-01-17 | 2023-01-19 | $1.23 | $330K | -7.3% | -6.5% | -7.3% |
| OTLK | BUY | 2021-12-03 | 2021-12-06 | $1.34 | $47K | -0.7% | -6.3% | +29.6% |
| OTLK | SELL | 2021-02-23 | 2021-02-25 | $2.09 | $18K | -3.4% | -1.0% | +23.1% |
| OTLK | SELL | 2021-02-12 | 2021-02-17 | $2.55 | $291K | -14.3% | -1.6% | -10.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.